Spark Investment Management’s Amicus Therapeutics FOLD Stock Holding History

Spark Investment Management’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-816,500	Closed	-$7.95M	–	427
2019 Q4	$7.95M	Sell	816,500 -381,400	-32%	-$3.49M	0.93%	10
2019 Q3	$9.61M	Sell	1,197,900 -343,500	-22%	-$3.73M	1.23%	13
2019 Q2	$19.2M	Sell	1,541,400 -65,000	-4%	-$825K	1.33%	5
2019 Q1	$21.8M	Buy	1,606,400 +822,700	+105%	+$10M	1.01%	15
2018 Q4	$7.51M	Buy	783,700 +659,300	+530%	+$7.25M	0.52%	47
2018 Q3	$1.5M	Buy	+124,400	New	+$1.74M	0.09%	311
2018 Q2	–	Sell	-281,700	Closed	-$4.24M	–	676
2018 Q1	$4.24M	Buy	281,700 +10,800	+4%	+$164K	0.27%	119
2017 Q4	$3.9M	Buy	+270,900	New	+$3.72M	0.21%	155
2016 Q3	–	Sell	-252,300	Closed	-$1.38M	–	843
2016 Q2	$1.38M	Buy	+252,300	New	+$1.76M	0.13%	256
2014 Q4	–	Sell	-166,400	Closed	-$988K	–	730
2014 Q3	$988K	Buy	+166,400	New	+$872K	0.15%	211

Other funds holding FOLD

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Spark Investment Management's FOLD Position: Q1 2020 in Review

Spark Investment Management sold out of Amicus Therapeutics (FOLD) in Q1 2020, closing a stake of 816,500 shares — an estimated $7.95M sold.

Spark Investment Management first reported a position in FOLD in Q3 2014 and held it in 10 quarters. The position peaked at $21.8M in Q1 2019. 202 funds tracked by Wall St. Rank hold FOLD as of Q1 2020.

Spark Investment Management reported no remaining Amicus Therapeutics position as of Q1 2020 after selling out during the quarter.
Spark Investment Management sold 816,500 Amicus Therapeutics shares in Q1 2020, an estimated $7.95M.
Spark Investment Management first reported a position in Amicus Therapeutics in Q3 2014 and held it in 10 quarters.
Spark Investment Management's Amicus Therapeutics position peaked at $21.8M in Q1 2019.
202 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2020.

Based on Spark Investment Management's 13F filing for Q1 2020, filed 12 May 2020.